Clinical Trials Sponsored by Vifor Pharma España, S.L.

Total 7 results

Fundacion Profesor Novoa Santos
ODDS , S.L.; Vifor Pharma España, S.L.

Completed

Feasibility of Implementation of Recommended Standards in Patients With Heart Failure (HFOutcomesSP)

Heart Failure

Spain
Vifor Pharma
SGS S.A.

Completed

Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age (Prefer)

Iron Deficiency

Austria
Grupo Español Multidisciplinar de Melanoma
Roche Farma, S.A; Pivotal S.L.

Completed

Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma

Melanoma

Spain
Sociedad Española de Trasplante
Roche Farma, S.A

Completed

Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients (SIMPLICITY)

Opportunistic Infections

Spain
Grupo Español de Tumores Huérfanos e Infrecuentes
Astellas Pharma Inc; Apices Soluciones S.L.

Completed

Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study (GREKO III)

Ovarian Cancer

Spain
Sociedad Española de Trasplante Hepático
Roche Farma, S.A

Unknown

Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients (VHENUS)

Hepatitis C | Cytomegalovirus Infection

Spain
Andres muñoz
Hospital Clinic of Barcelona; LEO Pharma; Hospital General Universitario Elche; Hospital Universitario Ramon y Cajal and other collaborators

Completed

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient (ONCOTHROMB)

Genetic Predisposition | Cancer-associated Thrombosis

Spain

3

Subscribe